PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

An important breakthrough by IRCM researchers in hematopoiesis and the development of B cells

A team led by Dr. Tarik Möröy identifies a new regulator playing a critical role in the development of B cells

2010-12-23
(Press-News.org) A team at the Institut de recherches cliniques de Montréal (IRCM) led by Dr. Tarik Möröy, President and Scientific Director of the institute and Director of the Hematopoiesis and Cancer research unit, will be publishing an important breakthrough in tomorrow's issue of Immunity, a scientific journal from the Cell Press group. The researchers identified a new regulator playing a critical role in the development B cells, which produce antibodies.

Antibodies circulate through the blood and protect against infectious diseases originating from bacteria or viruses. A lack of antibodies causes the immune system to be severely compromised against infections, and is therefore life-threatening. By producing specific antibodies, mature functional B cells are essential for the body's immune response. The regulator discovered by the researchers is a transcription factor called Miz-1, which is needed for the proper development and maturation of B cells in the bone marrow. This maturation process also requires a growth factor called Interleukin-7 (IL-7) that enables the development of B cells by providing it with the necessary survival signals.

"We initially wanted to clarify the role of Miz-1 during hematopoiesis, which is the formation of all blood cellular components," explains Dr. Christian Kosan, Research Associate in Dr. Möröy's research unit and the study's first author. "Surprisingly, our study demonstrated that Miz-1 is required predominantly for the very early stages of B-cell development in the bone marrow. For instance, after deleting the Miz-1 gene in a mouse, we discovered that it had almost completely lost its ability to generate B cells. "

Upon closer evaluation, the research team found that Miz-1 has a very particular function: it is required for IL-7 to effectively trigger the maturation of B cells in the bone marrow. For that reason, mice lacking the Miz-1 transcription factor were immunocompromised, and with this severe defect in B-cell production, a pathogen invasion would most certainly lead to rapid death.

"The important breakthrough in this study is the discovery that the IL-7 signaling pathway uses the transcription factor Miz-1 to ensure both B-cell survival and maturation," adds Dr. Möröy. "Our research project therefore confirmed the importance of this signaling pathway for the development of antibody-producing cells. Our next step will be to study the impact of Miz-1 in the development of B-cell leukemia. If this regulator is necessary for the production of B cells, it is possible that it is also required for the development of B-cell leukemia. It may thus be a target for therapeutic interventions in the treatment of this type of blood cancer."

INFORMATION:

Ingrid Saba, a graduate student in the IRCM's Hematopoiesis and Cancer research unit, is the second author of the study. This research project was conducted in collaboration with Dr. Martin Eilers, professor at the University of Würzburg (Germany), and his team. The study was supported by a grant from the Canadian Institutes of Health Research (CIHR) and the Canada Research Chair (Tier 1) held by Dr. Möröy.

For more information, please refer to the article summary published by Immunity: http://www.cell.com/immunity/abstract/S1074-7613(10)00458-9.

END



ELSE PRESS RELEASES FROM THIS DATE:

Carnegie Mellon researchers discover mechanism for signaling receptor recycling

Carnegie Mellon researchers discover mechanism for signaling receptor recycling
2010-12-23
PITTSBURGH—An international team of researchers led by Carnegie Mellon University's Manojkumar Puthenveedu has discovered the mechanism by which signaling receptors recycle, a critical piece in understanding signaling receptor function. Writing in the journal Cell, the team for the first time describes how a signaling receptor travels back to the cell membrane after it has been activated and internalized. Signaling receptors live on the cell membrane waiting to be matched with their associated protein ligand. When they meet, the two join together like a lock and key, ...

York U study pinpoints part of brain that suppresses instinct

2010-12-23
TORONTO, December 22, 2010 − Research from York University is revealing which regions in the brain "fire up" when we suppress an automatic behaviour such as the urge to look at other people as we enter an elevator. A York study, published recently in the journal Frontiers in Human Neuroscience, used fMRI (functional Magnetic Resonance Imaging) to track brain activity when study participants looked at an image of a facial expression with a word superimposed on it. Study participants processed the words faster than the facial expressions. However, when the word did ...

A new method is developed for predicting shade improvement after teeth bleaching

2010-12-23
Researchers at the University of Granada have developed a new method for predicting the precise shade that a bleaching treatment will bring about for a patient's teeth. What is innovative about this method is that it allows researchers to successfully predict the outcome of a bleaching treatment, which will have a significant impact on such treatments, which are becoming more frequent. At present, dental offices routinely employ carbomide peroxide bleaching agents for tooth discoloration. As bleaching treatments have soft side effects –all of them temporary and mild– ...

Eindhoven University builds affordable alternative to mega-laser X-FEL

Eindhoven University builds affordable alternative to mega-laser X-FEL
2010-12-23
Stanford University in the USA has an X-FEL (X-ray Free Electron Laser) with a pricetag of hundreds of millions. It provides images of 'molecules in action', using a kilometer-long electron accelerator. Researchers at Eindhoven University of Technology (TU/e) have developed an alternative that can do many of the same things. However this alternative fits on a tabletop, and costs around half a million euro. That's why the researchers have jokingly called it 'the poor man's X-FEL'. It's one of the few remaining 'holy grails' of science: a system that allows you to observe ...

Some firms benefit from increased spending despite recession

2010-12-23
During recessions, increased spending on research and development and on advertising can benefit certain types of firms and punish others, according to researchers, who identified the firm types that spend most effectively. More than 10,000 firm-years of data from publicly listed U.S. firms from 1969 to 2008 -- a period that included seven recessions -- were examined by Gary L. Lilien, Distinguished Research Professor of Management Science, Penn State Smeal College of Business; Raji Srinivasan, University of Texas; and Shrihari Sridhar, Michigan State University. The ...

Cord blood cell transplantation provides improvement for severely brain-injured child

2010-12-23
Citation: Jozwiak, S.; Habich, A.; Kotulska, K.; Sarnowska, A.; Kropiwnicki, T.; Janowski, M.; Jurkiewicz, E.; Lukomska, B.; Kmiec, T.; Walecki, J.; Roszkowski, M.; Litwin, M.; Oldak, T.; Boruczkowski, D.; Domanska-Janik, K. Intracerebroventricular Transplantation of Cord Blood-Derived Neural Progenitors in a Child With Severe Global Brain Ischemic Injury. Cell Medicine 1(2):71-80; 2010. The editorial offices for Cell Medicine are at the Center of Excellence for Aging and Brain Repair, College of Medicine, the University of South Florida. Contact, David Eve, PhD. ...

Photons vs. protons for treatment of spinal cord gliomas

2010-12-23
COLUMBUS, Ohio – A study comparing the long-term outcomes of patients with spinal-cord tumors following radiation therapy suggests that certain subsets of patients have better long-term survival. It also suggests that photon-based radiation therapy may result in better survival than proton-beam therapy, even in patients with more favorable characteristics. This is the first study to report the long-term outcomes of spinal-cord tumor patients treated by modern radiotherapy techniques, the researchers say. Gliomas, which represent most spinal cord tumors, develop in about ...

Which comes first: Exercise-induced asthma or obesity?

2010-12-23
Montreal, December 22, 2010 – Obese people are more likely to report exercise as a trigger for asthma. Of 673 people evaluated in a new study whose results are published in the journal The Physician and Sportsmedicine, 71 percent of participants reported exercise-induced asthma (ETA). The findings are important, since 2.3 million Canadians are affected by asthma according to Statistics Canada. ETA affects up to 90 percent of asthma sufferers, says lead author Simon Bacon, a professor at the Concordia Department of Exercise Science and a researcher at the Hôpital du ...

Imagine your future self: Will it help you save money?

2010-12-23
Why do people choose present consumption over their long-term financial interests? A new study in the Journal of Consumer Research finds that consumers have trouble feeling connected to their future selves. "This willingness to forego money now and wait for future benefits is strongly affected by how connected we feel to our future self, who will ultimately benefit from the resources we save," write authors Daniel M. Bartels (Columbia Business School) and Oleg Urminsky (University of Chicago). When we think of saving money for the future, the person we think of can ...

Fast sepsis test can save lives

Fast sepsis test can save lives
2010-12-23
Although it is the third most frequent cause of death in Germany, blood poisoning is frequently underestimated. In this country, 60,000 persons die every year from some form of sepsis, almost as many as from heart attacks. The Sepsis Nexus of Expertise states that patients arriving at the intensive care ward with blood poisoning only have a 50% chance of surviving. One of the reasons for the high mortality rate is the fact that patients are not correctly treated due to late diagnosis. The doctor and the patient used to have to wait as much as 48 hours for the laboratory ...

LAST 30 PRESS RELEASES:

Vaccine gaps rooted in structural forces, not just personal choices: SFU study

Safer blood clot treatment with apixaban than with rivaroxaban, according to large venous thrombosis trial

Turning herbal waste into a powerful tool for cleaning heavy metal pollution

Immune ‘peacekeepers’ teach the body which foods are safe to eat

AAN issues guidance on the use of wearable devices

In former college athletes, more concussions associated with worse brain health

Racial/ethnic disparities among people fatally shot by U.S. police vary across state lines

US gender differences in poverty rates may be associated with the varying burden of childcare

3D-printed robotic rattlesnake triggers an avoidance response in zoo animals, especially species which share their distribution with rattlers in nature

Simple ‘cocktail’ of amino acids dramatically boosts power of mRNA therapies and CRISPR gene editing

Johns Hopkins scientists engineer nanoparticles able to seek and destroy diseased immune cells

A hidden immune circuit in the uterus revealed: Findings shed light on preeclampsia and early pregnancy failure

Google Earth’ for human organs made available online

AI assistants can sway writers’ attitudes, even when they’re watching for bias

Still standing but mostly dead: Recovery of dying coral reef in Moorea stalls

3D-printed rattlesnake reveals how the rattle is a warning signal

Despite their contrasting reputations, bonobos and chimpanzees show similar levels of aggression in zoos

Unusual tumor cells may be overlooked factors in advanced breast cancer

Plants pause, play and fast forward growth depending on types of climate stress

University of Minnesota scientists reveal how deadly Marburg virus enters human cells, identify therapeutic vulnerability

Here's why seafarers have little confidence in autonomous ships

MYC amplification in metastatic prostate cancer associated with reduced tumor immunogenicity

The gut can drive age-associated memory loss

Enhancing gut-brain communication reversed cognitive decline, improved memory formation in aging mice

Mothers exposure to microbes protect their newborn babies against infection

How one flu virus can hamper the immune response to another

Researchers uncover distinct tumor “neighborhoods”, with each cell subtype playing a specific role, in aggressive childhood brain cancer

Researchers develop new way to safely insert gene-sized DNA into the genome

Astronomers capture birth of a magnetar, confirming link to some of universe’s brightest exploding stars

New photonic device, developed by MIT researchers, efficiently beams light into free space

[Press-News.org] An important breakthrough by IRCM researchers in hematopoiesis and the development of B cells
A team led by Dr. Tarik Möröy identifies a new regulator playing a critical role in the development of B cells